France· FR:66976254
CELLUVISC 4 mg/0,4 ml, collyre en récipient unidose
A carmellose product containing carmellose sodique, registered in France by ABBVIE, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Carmellose is registered in 3 of 19 countries.
Countries holding a registration under ATC S01XC08 (carmellose), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Carmellose · ATC S01XC08
3 / 19 countries
- Franceprice
- Germany
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CARMELLOSE SODIQUE
- Manufacturer
- ABBVIE
- Country
- France (FR)
- ATC code
- S01XC08
- ATC class
- Carmellose
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip13340093379744730 récipient(s) unidose(s) polyéthylène de 0,4 mlEUR 2.92
- cip13340093379750890 récipient(s) unidose(s) polyéthylène de 0,4 mlEUR 7.82
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carmellose in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsCelluvisc, oogdruppels 10 mg/mlAbbVie B.V.
- United KingdomAaqEye Carmellose 0.5% eye dropsEssential-Healthcare Ltd
- SpainACUVISC 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSISTiedra Farmaceutica S.L.
- United StatesDRMITSUI HYDROCOLLOID WOUNDYIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED
- IrelandCelluvisc 0.5 % w/v eye drops solution, unit doseAbbVie Limited
- SwitzerlandCellufluid
- CzechiaCELLUFLUIDAbbVie s.r.o., Praha
- GermanyCelluviscAbbvie Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Czechia · Cellufluid
- Denmark · Celluvisc
- Spain · Carmelosa Qualigen, Carmelosa Stada
- Finland · Celluvisc
- United Kingdom (Northern Ireland) · Celluvisc
- Greece · Refresh Plus
- Ireland · Celluvisc
- Italy · Celluvisc
- Netherlands · Cellufluid, Celluvisc
- Portugal · Celluvisc
- Sweden · Cellufluid, Celluvisc
- Slovakia · Cellufluid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e7220d9-812f-49e1-885a-923589488cd6 GET /v1/drugs/1e7220d9-812f-49e1-885a-923589488cd6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66976254",
"date_amm": "1994-09-15",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CARMELLOSE SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about carmellose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.